|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 高危患者目标血压与心血管病预后显示文摘指南推荐血压目标值应〈140/90 mmHg(1mmHg=0.133kPa)以减少心血管事件的发生。但与其他心血管病预后(如冠状动脉事件)相比,包括脑卒中及心力衰竭在内的心血管病预后与收缩压下降关系更密切。一些心血管事件(如冠状动脉事件)风险在收缩压低时亦增高,风险-收缩压关系呈J形曲线,而脑卒中与血压不是J形曲线关系。 | B?hm M Schumacher H Teo KK Lonn EM Mahfoud F Mann JF Mancia G Redon J Schmieder RE Sliwa K Weber MA Williams BYusuf S 曲浥晨 叶鹏 | 2017 | 中华高血压杂志2017，25，6： | 14 |
| 2 | Albuminuria and risk ofcardiovascular events,death,and heart failure in diabetic andnondiabetic individuals显示文摘 | Gerstein HC Mann JF Yi Q | 2001 | JAMA2001，286，4： | 1 |
| 3 | Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial 显示文摘 | Mann JF Gerstein HC Pogue J | 2001 | Ann Intern Med2001，134，8： | 1 |
| 4 | Chronic kidney disease: effects on the cardiovascular system显示文摘 | Schiffrin EL Lipman ML Mann JF | 2007 | Circulation2007，116，7： | 1 |
| 5 | Cardiovascular risk in patients with mild renal in suficiency显示文摘 | Mann JF Gerstein HC Dulau | 2003 | Am J Kidney2003，7，84： | 1 |
| 6 | Chronic kidney disease: effects on the cardiovascular system显示文摘 | Schiffrin EL Lipman ML Mann JF | 2007 | Circulation2007，116，1： | 1 |
| 7 | Renal outcomes with telmisarran, ramipril, or both,in people at high vascular risk (the ONTARGET study) : a muhicentre, randomised ,double-blind,controlled trial显示文摘 | Mann JF Schmieder RE Mc-Queen M | 2008 | Lancet2008，372，9638： | 1 |
| 8 | Chronic kidney disease: effects on the cardiovascular system 显示文摘 | Schiffrin EL Lipman ML Mann JF | 2007 | Circulation2007，116，1： | 1 |
| 9 | Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes:results of the ONTARGET trial显示文摘 | Mann JF Anderson C Gao P | | 0，，02： | 1 |
| 10 | Cardiovascular risk in patients with mild renal insufficiency显示文摘 | Mann JF Gerstein HC Dulau-Florea I | 2003 | Kidney Int Suppl2003，，84： | 1 |
| 11 | Avosentan for overt diabetic nephropathy显示文摘 | Mann JF Green D Jamerson K | 2010 | J Am Soc Nephrol2010，21，3： | 1 |
| 12 | Renal out- comes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicenter, randomised, double-blind, controlled trial显示文摘 | MANN JF SCHMIEDER RE McQUEEN M | 2008 | Lancet2008，372，9638： | 1 |
| 13 | Albuminuria and risk of cardio- vascular events,death,and heart failure in diabetic and nondiabetic individuals显示文摘 | Gerstein HC Mann JF Yi Q | 2001 | JAMA2001，286，4： | 1 |
| 14 | Albuminuria and riskof cardiorascular events, death, and heart fuilure in dia-betic and nondiabetic indiriduals显示文摘 | Gerstein HC Mann JF Yi Q | 2001 | JAMA2001，286，4： | 1 |
| 15 | Albuminuria and risk of cardiovascular events, death ,and heart failure in diabetic and nondiabetic individuals显示文摘 | Gerstein HC Mann JF Yi Q | 2001 | JAMA2001，286，： | 1 |
| 16 | Albuminuria and risk of cardi ovascular events,death?and heart failure in diabetic and nondiabe- fic individuals显示文摘 | Gerstein HC Mann JF Yi Q | 2001 | JAM A2001，286，4： | 1 |
| 17 | Dual inhibition of the renin- angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial 显示文摘 | Mann JF Anderson C Gao P | 2013 | J Hypertens2013，31，2： | 1 |
| 18 | Albuminuria and risk of cardiovascular events ,death,and heart failure in dia- betic and nondiabetic individuals 显示文摘 | Gerstein HC Mann JF Yi Q | 2001 | JAMA2001，286，4： | 1 |
| 19 | Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy:the prevent single-centre,randomised,controlled trial显示文摘 | Mann MJ Whittemore AD Donaldson MC Belkin M Conte MS Polak JF | 1999 | Lancet1999，354，9189： | 1 |
| 20 | Chronic kidney disease: effects on the cardiovascular system 显示文摘 | Schiffrin EL Lipman ML Mann JF | 2007 | Circulation2007，116，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员